Anatara Lifesciences Director Increases Shareholding

Anatara Lifesciences Ltd (AU:ANR) has released an update.

Anatara Lifesciences Limited has announced a change in director David Brookes’ interest in the company’s securities, with the acquisition of 500,000 ordinary shares through his Brookes Superfund and Dahlbrook Family Trust for $25,000. This update may interest investors tracking the company’s leadership and stock movements.

For further insights into AU:ANR stock, check out TipRanks’ Stock Analysis page.